Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMK9L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,687
Award facts
- Contract value 100% obligated
- $15,686.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,686.92 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pens on January 30, 2026. This is a firm fixed-price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026). The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 2, 2026. Dupixent is a biologic medication indicated for multiple conditions including atopic dermatitis, eosinophilic esophagitis, and asthma, supporting military healthcare system requirements.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company operates as a competitively awarded prime contractor for the DLA Medical Supply Chain, delivering a comprehensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military treatment facilities and other federal healthcare programs. This delivery order represents one of numerous pharmaceutical supply transactions executed under AmerisourceBergen's broader IDC vehicle, demonstrating the company's ongoing role in fulfilling essential medication requirements for the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FMK9L?
SPE2DR26FMK9L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FMK9L worth?
The government has obligated $15,687 on SPE2DR26FMK9L.
Is contract SPE2DR26FMK9L an order under another contract?
Yes. SPE2DR26FMK9L is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK9L competed?
The extent of competition for SPE2DR26FMK9L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award